MIR4779: A Drug Target / Disease Biomarker (G100616159)

MIR4779: A Drug Target / Disease Biomarker

MIR4779, also known as interleukin-4779, is a protein that is expressed in various tissues throughout the body. It is a member of the Interleukin-4 family, which is a group of cytokines that play a crucial role in the immune system. MIR4779 has been identified as a potential drug target and has been shown to have a number of potential therapeutic applications.

MIR4779 is a 21-kDa protein that is expressed in a variety of tissues, including the liver, spleen, and muscle. It is a key component of the interleukin-4 signaling pathway, which is a complex intracellular signaling system that is involved in the regulation of immune and inflammatory responses. MIR4779 is a critical regulator of this pathway, and its function is essential for the development and maintenance of a healthy immune system.

One of the key functions of MIR4779 is its role in the regulation of inflammation. MIR4779 has been shown to play a critical role in the regulation of the production and activation of immune cells, including T cells and natural killer cells. It has been shown to inhibit the production of pro-inflammatory cytokines, such as TNF-alpha and IL-12, and to promote the production of anti-inflammatory cytokines, such as IL-10. These actions are important for the regulation of a healthy immune system and for the prevention of autoimmune diseases.

Another important function of MIR4779 is its role in the regulation of cell survival. MIR4779 has been shown to play a critical role in the regulation of cell survival and has been shown to promote the survival of a variety of cell types, including immune cells and cancer cells. This survival-promoting function of MIR4779 is important for the regulation of cancer development and for the development of effective cancer treatments.

MIR4779 has also been shown to play a critical role in the regulation of cellular processes that are important for the development and maintenance of tissues. MIR4779 has been shown to promote the migration and invasion of cells, and to play a role in the regulation of cell adhesion and cell-cell interactions. These actions are important for the development and maintenance of tissues and for the regulation of normal cellular processes.

In addition to its role in the regulation of inflammation and cellular processes, MIR4779 has also been shown to play a critical role in the regulation of immune responses. MIR4779 has been shown to play a critical role in the regulation of the activation and proliferation of immune cells, including T cells and natural killer cells. It has been shown to promote the production of antibodies and to regulate the production of other immune cells, such as memory T cells. These actions are important for the regulation of a healthy immune system and for the prevention of infections and other diseases.

Given its multiple functions and its potential as a drug target, MIR4779 is an attractive target for therapeutic intervention. MIR4779 has been shown to play a critical role in the regulation of a variety of cellular processes, including inflammation, cell survival, and immune responses. It is possible that MIR4779 may be a useful drug target for the treatment of a variety of diseases, including autoimmune diseases, cancer, and infections. Further research is needed to fully understand the functions of MIR4779 and to develop effective treatments based on this protein.

Protein Name: MicroRNA 4779

The "MIR4779 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4779 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C